title: Effect of L-asparaginase on insulin secretion from isolated rat islets of Langerhans.
abstract: The effects of L-asparaginase were evaluated on glucose-induced insulin release from isolated rat islets of Langerhans. Islets were obtained by enzymatic digestion of pancreas from Sprague-Dawley rats. The study of L-asparaginase effects on insulin secretion was performed in a static incubation of islets. Insulin secretion was measured at 60 min of incubation with different secretagogues with and without L-asparaginase. L-Asparaginase at concentrations from 310 to 5,000 U/ml could inhibit the glucose-induced insulin secretion in a dose-dependent manner. This effect was not recovered after incubation in the absence of the drug for another 2 h. The half-maximal inhibitory effect of the enzyme on insulin secretion was observed at L-asparaginase concentrations of 1,000 U/ml. Tolbutamide (200 microM) and ketoisocaproic acid (20 mM) did not induce insulin secretion in the presence of moderately high L-asparaginase concentrations. L-Asparaginase did not inhibit glucose-induced insulin secretion in the presence of isobutyl-methyl-xanthine (IBMX) (20 microM) or forskolin (20 microM). L-Asparaginase promoted a decrease in total c-AMP in isolated rat islets at concentrations from 500 to 1,500 U/ml when they were stimulated by glucose. If islets were treated with IBMX or forskolin, L-asparaginase did not inhibit the glucose-induced total c-AMP levels in islets.
authors.affiliation: Department of Endocrinology and Nutrition, Hospital de la Santa Cruz y de San Pablo, Autonomous University of Barcelona, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Pou
authors.forename: T
authors.initials: T
authors.lastname: Cervera
authors.forename: A
authors.initials: A
authors.lastname: Perez
authors.forename: M A
authors.initials: MA
authors.lastname: Ortiz
authors.forename: J A
authors.initials: JA
authors.lastname: Arroyo
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D001215:Asparaginase / Q000494:pharmacology*; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007651:Keto Acids / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D014044:Tolbutamide / Q000494:pharmacology
chemical_list: D007328:Insulin; D007651:Keto Acids; D005576:Colforsin; C013082:alpha-ketoisocaproic acid; D014044:Tolbutamide; D000242:Cyclic AMP; D001215:Asparaginase; D005947:Glucose; D015056:1-Methyl-3-isobutylxanthine